Authorities recover body under Gold Creek overpass

first_imgJuneau | Public Safety | Southeast | SyndicatedAuthorities recover body under Gold Creek overpassJuly 14, 2015 by Jeremy Hsieh, KTOO Share:Flowers in the fence over the Gold Creek bridge on Monday. (Photo by Elizabeth Jenkins/KTOO)Authorities recovered a body Tuesday morning under the Gold Creek overpass downtown.Juneau police identified her as Macaria Wallace, age 51, of Kake.Police do not suspect foul play.Indigents often use overpass as shelter. Mariya Lovishchuk, head of The Glory Hole emergency shelter and soup kitchen, confirmed Wallace had used her organization’s services.Flowers were left on the fence Monday overlooking the bridge.Share this story:last_img read more

Pandemic causes housing headaches for Alaska lawmakers returning to Juneau for next legislative session

first_imgCoronavirus | Juneau | Politics | State GovernmentPandemic causes housing headaches for Alaska lawmakers returning to Juneau for next legislative sessionDecember 14, 2020 by Becky Bohrer, Associated Press Share:Alaska State Capitol building (left) and Dimond Courthouse, Juneau, Alaska, January. 23, 2017. (Photo by Skip Gray/360 North)JUNEAU – Alaska lawmakers who each year relocate to a capital city accessible only by plane or boat are facing challenges in getting settled ahead of what is expected to be a difficult legislative session overshadowed by COVID-19.The Baranof Hotel, a 1939 art deco showpiece in downtown Juneau with about 200 guest rooms, laundry service and a restaurant just blocks from the Capitol, is closed through the winter due to the pandemic.Short-term housing rental offerings have been sluggish compared to last year, officials say, though they expect more places to become available as the session approaches and plenty of hotel options, as many events have been waylaid by the virus.Still, with just over a month before session is set to begin, some lawmakers are waiting to lock down digs. One factor: uncertainty about how – and for how long – lawmakers plan to meet.“If I need to, I’ll sleep in my office,” Sen. Scott Kawasaki, a Fairbanks Democrat, said with a laugh.For years, he has shared a place with a fellow lawmaker. But he said the place they had last session is booked, and he was wary about signing a contract on a fallback option if lawmakers end up deciding to take an extended recess, as they did earlier this year.Lawmakers would first have to meet in person if they wanted to change their rules to allow, for example, remote voting, said Jessica Geary, executive director of the Legislative Affairs Agency.Kawasaki also wasn’t sure about bringing a car. Such a journey for lawmakers and staff on Alaska’s limited road system can involve crossing into Canada and driving across often brutally cold, treacherous landscapes to reach a ferry to get to Juneau.Nonessential travel through Canada is restricted but Geary said a special arrangement with the Canadian Consulate allows legislators and staff passage on their way to Juneau.Planning for how long to be in Juneau in recent years – outside the pandemic – has been a crapshoot, with lawmakers, facing ongoing budget deficits, often requiring special sessions beyond their constitutionally allowed four-month regular sessions.In some cases, as the work dragged on, lawmakers had to scramble for alternative lodging as their leases expired and as Juneau’s tourist season began.This year was different: Faced with the coronavirus threat, lawmakers passed a budget early, in late March, before taking an extended break. During part of the recess, they were automatically approved to claim a daily $287 allowance that some said helped pay lease and storage obligations.Not all lawmakers took the allowance or took it for the full allowable period. The Legislature met again briefly in May before adjourning.While there was an expectation lawmakers would return to consider Republican Gov. Mike Dunleavy’s appointments to boards and commissions and weigh an extended disaster declaration related to the pandemic, that never happened.Legislative leaders have said they lacked the votes needed for lawmakers to call themselves into a special session, and they raised concern with Dunleavy unilaterally issuing a new declaration.House Speaker Bryce Edgmon, an independent from Dillingham, about 860 miles from Juneau, said pandemic concerns come at a time when lawmakers will need to make tough budget decisions.“I’m fairly anxious as to what this upcoming session could bring, on a number of fronts,” he said.Rep. Mike Prax, a North Pole Republican who stayed at the Baranof during this year’s session, called its temporary closure a “bummer.” He said he doesn’t want to bring a car and hopes to find a place within walking distance to the Capitol. Several hotels are within a mile.Lawmakers in other states are wrestling with how to conduct their upcoming sessions. In Washington, lawmakers plan a mix of virtual meetings and on-site votes. In New Mexico, lawmakers are debating a potential delay to the start of session in January or holding proceedings at a convention center with space to spread out.In Alaska, a council that handles legislative business during the interim approved a contract for screening and testing at the Capitol for the upcoming session and proposed a code of conduct that includes testing before or upon arrival in Juneau and avoiding non-essential trips from the city. Geary said the next Legislature can decide whether to follow or change the policies.Juneau City Manager Rorie Watt said he feels comfortable having the Legislature return, citing in part the protocols the council adopted.He also said Juneau has good testing capacity and that residents have been good about wearing masks, keeping their distance and avoiding large groups.Sen. Donny Olson, a Democrat, usually brings his wife and six children with him for session from the tiny community of Golovin, about 1,000 miles from Juneau.He said finding a comfortable place with room for the kids to play is a factor as he and his wife weigh whether he should come alone, as is schooling. He said his children have had in-classroom instruction in Golovin. Juneau schools recently announced plans to resume in-person classes in January.Olson, who is a doctor, said he was concerned some might not cooperate with the proposed protocols at the Capitol meant to guard against the virus.“And because of that, trying to go ahead and safeguard myself and my children against the COVID is something that is high on my priority list,” he said.Share this story:last_img read more

News / Shippers demand innovation from their favourite 3PLs, but will they pay for it?

first_img Freight service providers are trapped in a classic Catch-22 situation with their major clients, who expect more innovation from their logistics suppliers but frequently fail to pay for it.That was the major conclusion from a recent “voice of the customer” survey, conducted by supply chain community SCM World, of hundreds of multinationals’ transport and supply chain managers on their use of third-party logistics providers.The survey asked respondents to rate their logistics providers on five key service metrics: reliability; speed of response to queries and problems; innovation, in terms of how the 3PL brings new ideas and solutions to customer supply chains; value for money; and scale of impact, in terms of “how vital a service provider is to the shippers’ organisations”. They were asked to rate on scale of one to five, with one representing very poor and five representing excellent.All espondents rated their 3PLs as generally being between three and four on all metrics – however, innovation was routinely rated lowest.Kevin O’Marah, SCM World chief content officer, said: “I think there is an endemic problem from the buyers’ side. They want something beyond just shifting boxes, but they end up grinding down their suppliers on price – the buyers are not paying for what they want, which they say is innovation.“Here is the Catch-22: the qualitative conversations show a desire for more innovation and strategic supply chain thinking, and yet when it comes to the negotiations the discussion goes back to rates and routes.“How do you break out of that self-reinforcing cycle? Because you are not going to get the investment in innovation – to be driven into buying just on cost essentially shuts off the font of innovation that people are developing because service providers have to be paid for innovation, they can’t just do it on their own dime,” he said.Mr O’Marah added, however,  that there were also some shippers that had decided to accept higher freight rates on certain lanes because “they realise they will save money in other ways”.Barry Blake, vice-president of research, added: “In every follow-up discussion we had with [3PL] customers, they said their logistics suppliers needed to be doing more on innovation.”However, he questioned: “But how important is innovation? I think the customer really needs to be more honest with their 3PLs on the need for innovations, while 3PLs need to clarify where their expertise lie.”The top ten 10 3PLs  named by respondents in the poll were DHL, FedEx, UPS, Kuehne + Nagel, DB Schenker, Ceva, Exel, Agility, CH Robinson and Ryder – reflecting that the single largest group of respondents were in the US.FedEx scored highest on reliability, speed and scale of impact, while UPS scored highest on innovation.The survey also revealed that none of the logistics providers scored poorly – rating a score of one or two. By Gavin van Marle 13/08/2014last_img read more

What you missed at ASCO? A lot, as cancer research hastens on

first_img Senior Writer, Biotech Adam is STAT’s national biotech columnist, reporting on the intersection of biotech and Wall Street. He’s also a co-host of “The Readout LOUD” podcast. Log In | Learn More By Adam Feuerstein and Matthew Herper June 4, 2019 Reprints What is it? CHICAGO — It was, by all accounts, a pretty slow year at the annual meeting of the American Society of Oncology. But the pace of cancer research is so fast that even during a slow year a lot happens. Here’s our review of some of the most important developments revealed at the largest annual meeting of cancer doctors.Targeted therapies on topFor a few years, most big cancer meetings have been all about immunotherapy, with the spotlight on big, practice-changing clinical trials showing how the immune system can be directed to kill cancer cells. Unlock this article — plus daily coverage and analysis of the biotech sector — by subscribing to STAT+. First 30 days free. GET STARTED Matthew Herper [email protected] Adam Feuerstein/STAT @adamfeuerstein Daily reporting and analysis The most comprehensive industry coverage from a powerhouse team of reporters Subscriber-only newsletters Daily newsletters to brief you on the most important industry news of the day STAT+ Conversations Weekly opportunities to engage with our reporters and leading industry experts in live video conversations Exclusive industry events Premium access to subscriber-only networking events around the country The best reporters in the industry The most trusted and well-connected newsroom in the health care industry And much more Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr. STAT+ is STAT’s premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.center_img Biotech [email protected] GET STARTED Senior Writer, Medicine, Editorial Director of Events Matthew covers medical innovation — both its promise and its perils. @matthewherper What’s included? About the Authors Reprints Adam Feuerstein What you missed at ASCO? A lot, as cancer research hastens on Tags ASCObiotechnologycancerpharmaceuticalsSTAT+last_img read more

Patients will be the losers as Pelosi’s plan to control drug prices nearly strikes out

first_img Our 9 biggest questions about Nancy Pelosi’s drug pricing bill By Peter Kolchinsky Sept. 23, 2019 Reprints House Speaker Nancy Pelosi at a press conference on her drug pricing legislation in Washington last week. Win McNamee/Getty Images Leave this field empty if you’re human: Our growing mountain of generic drugs is a national treasure. Like a mortgage that is eventually paid off, what we pay for branded drugs — 1.3% of GDP — is a worthy investment, not an expense. Nothing else about health care goes generic: Surgery costs, for example are an ever-increasing rent. Drugs going generic without undue delay, as most do, is the price control we have long had and the only price control we need.Pelosi’s price controls are just another way of saying that the government — which still continues to invest in sugar subsidies — would prefer to stop investing in new medicines. That means our children’s and grandchildren’s health care will be no better than our own. America is better than that.Third time’s a charm: capping out-of-pocket costsOur creative drive to cure diseases should be the pride and joy of America, not a scapegoat for a broken health insurance system. Patients currently shoulder $61 billion of out-of-pocket drug costs. Some are financially ruined by what they are asked to pay, and many more give up on treatment. Their plight fuels outrage in the media and inflammatory rhetoric, leading many to blame innovators for the hardships insurance companies impose on patients.This is why I applaud the third part of Pelosi’s bill, which proposes much-needed insurance reforms to cap what patients pay out of pocket for the medicines they need. That’s the real solution patients have been waiting for. It would upgrade today’s health care insurance from the tattered, complex web that fails to catch millions of sick people each year to proper coverage that allows patients to afford what their physicians prescribe. We need additional reforms to ensure that all people are similarly protected.Only then will we have truly solved the affordability issue for patients.Peter Kolchinsky is a founder and managing partner of RA Capital Management and writes on the Biotech Social Contract. Privacy Policy About the Author Reprints First OpinionPatients will be the losers as Pelosi’s plan to control drug prices nearly strikes out Pelosi’s plan blocks price increases on existing drugs. To remain profitable, companies would have to launch new drugs at even higher prices than they would have otherwise, anticipating they wouldn’t be able to sell them in Europe and Japan and therefore would need to generate all their returns from U.S. sales. So over the longer term, the U.S. would shoulder even more of the cost of innovation than it does now.With her focus on what other countries pay, Pelosi appears to miss the point that it serves American patients for drug companies to get other countries to contribute at least something to the development of novel medicines. Yes, patients in those countries get medicines for less. But what American politicians should focus on is making sure that American patients have access to today’s treatments and the ones we have yet to invent.If America won’t let other countries pay less and then, later on, when those countries stop paying for drugs, won’t agree to make up the difference by paying more, then the funding for new drug development will dry up and there won’t be any novel drugs to fuel our debates about price and affordability.Second bad idea: outright price settingThe second part of Pelosi’s plan calls for government price controls on 250 drugs under Medicare. This means U.S. companies would not be allowed to set their own drug prices — even if they were the same as what other countries paid. The bill summary referred to these controls as a “negotiation” to bring down costs under Medicare, but its reach extends well beyond Medicare and doesn’t actually call for negotiation. Drug companies that do not acquiesce to pricing demands from the Department of Health and Human Services would face punitive taxes until they came to heel.The massive expense of drug development is borne almost exclusively by private investors, and there are not many of them. Fundamentally, Pelosi seems to believe that the U.S. government should decide how much reward to mete out to successful innovators. The premise of her proposal is that “innovation does not benefit Americans if they cannot afford it.” But when only 1 in 25 drug candidates makes it from preclinical studies through to FDA approval, no one is going to put money on the 25-to-1 longshot if the house can announce after the race is over that the actual payout will be 5-to-1. The pharmaceutical industry runs on profit margins of 10% to 20%, meaning there’s not much room to cut revenues before biotech becomes a giant nonprofit. The only logical response by companies would be to raise international prices to match those in the U.S., not to lower U.S. drug prices to match international ones. If other countries then cut back on their use of branded drugs, American companies will have to make up their losses by increasing prices.advertisement Related: Trump says it’s ‘great to see’ Pelosi’s drug pricing plan center_img What Pelosi has proposed is worse than the central planning ideology already debunked by the collapse of the Soviet Union, which at least paid inventors’ salaries while they worked for the state. If she believes the myth that the government already funds drug development, I can see how it would sound fair that the state should set the price for its own intellectual property. This belief is shared by other elected representatives, including Sens. Bernie Sanders (I-Vt.) and Rick Scott (R-Fla.), who have been spreading tales that U.S. taxpayers substantially fund the development of new medicines. But this isn’t true.The average National Institute of Health grant to a university researcher is under $1 million. Drug companies then risk an average of $1 to $2 billion to convert that basic research into a single FDA-approved drug.Although most drugs are invented by industry, there’s no question that government-funded university research germinates some promising seeds that can sprout into lifesaving medicines. When it’s time to bring their discoveries from the lab to the clinic, universities seek to partner with companies and receive both guaranteed payments and royalties if those drugs succeed.Drug companies pay workers, vendors, and manufacturers, and issue dividends to investors — all transactions taxed by Uncle Sam. No one is exploiting taxpayers here: Biopharma innovators commercialize new medicines for society while generating revenue for both the U.S. Treasury and research universities.The math behind drug development is often twisted by pharma’s critics to suggest that there is widespread price gouging in the industry. But the drug industry’s profit margin fluctuates between 10% and 20%, less than that for the software and oil and gas industries. And after all of the rebates that are already negotiated by insurers — which should be passed onto patients but aren’t — there is little room for further cuts. Shaving even 20% off net drug prices would render the industry profitless and wipe out most executive compensation. While that might please some, a 20% discount wouldn’t make an immuno-oncology treatment affordable to a patient with poor insurance coverage.Generics were once novel drugsPrices are generally set at levels the market requires to keep the innovation engine churning out new drugs, which are only temporarily expensive before going generic, remaining useful yet inexpensive in perpetuity. As long as drugs keep going generic, the industry must keep inventing to stay afloat, which is good for patients. That drugs go generic when patents expire is the natural price control that’s always ensured that drugs offer great value in the long run. Related: Newsletters Sign up for D.C. Diagnosis An insider’s guide to the politics and policies of health care. First bad idea: one price for the U.S., E.U., and JapanPelosi would peg U.S. drug prices to those paid by Japan and several European single-payer health care systems whose restrictive policies offer fewer innovative medicines to their citizens. This is similar to what President Trump has proposed before. But this well-intentioned price control would most likely push U.S. prices up, not down. Here’s why. [email protected] Please enter a valid email address. Peter Kolchinsky This year has brought new treatments for osteoporosis, advanced bladder cancer, Ebola, tuberculosis, spinal muscular atrophy, and postpartum depression. And it’s only autumn — the season in which Congress and President Trump will decide to kill biomedical innovation with their proposals on drug prices just as we’re entering a new era of curative medicines.The press is reporting on “bipartisan efforts to lower drug prices,” taking for granted that any debate about drug prices presumes that there are drugs to price.House Speaker Nancy Pelosi finally released her three-part plan to lower drug prices last week. The first two parts would be terrible for patients. The third is exactly what we need.advertisement Tags Congressdrug developmentdrug pricinglast_img read more

Florida won’t make the COVID-19 vaccine mandatory, DeSantis says

first_imgTALLAHASSEE, Fla. – Governor Ron DeSantis made an announcement Thursday afternoon regarding a new COVID-19 treatment that could be given to those in Florida hospitals, as well as an update on the two vaccines being created. DeSantis said the state’s goal is to make COVID-19 vaccines available to all Floridians who want them, but the state won’t be mandating them.“That is going to be the choice of each and every Floridian,” he said in a video Thursday. LCSO among law enforcement agencies deploying officers to Texas, Arizona June 16, 2021 RELATEDTOPICS A Lee Health representative confirmed the hospital system has the ability to store the vaccine in an email sent Thursday afternoon, but said they haven’t gotten a response to see if they will be selected.Moderna’s vaccine, which also has a 95% effectiveness rate, can be refrigerated in normal temperatures. “That will potentially provide more flexibility,” DeSantis said.According to DeSantis, the federal government is estimating that by the end of December per approval from the FDA, about 40 million doses of both vaccines will be available — 25 million of Pfizer’s and 15 million of Moderna’s. Each person getting a vaccine will need two doses, meaning there will be “enough vaccine for 20 million Americans by the end of December,” DeSantis said.He said millions of doses are ready to ship “as we speak.” Once the FDA approves the vaccines, they will be shipped within the next 24 hours. “We expect our hospitals, hopefully, to receive these within the next 3 to 6 weeks,” DeSantis said. He said that after, or possibly at the same time that hospitals are getting the vaccine, both CVS and Walgreens locations will also receive the vaccine to administer to those living in long-term care facilities. As of right now, 2,000 long-term care facilities have registered to get their residents vaccinated as soon as they are able.The new treatment, which is being developed by Eli Lilly, is a monoclonal antibody cocktail. It’s administered through an IV, and takes about an hour, DeSantis said. “It is best used for people who are at high-risk of severe complications from COVID-19,” DeSantis said in a video released Thursday. This treatment would be given to people who go to emergency rooms showing symptoms of the coronavirus. These patients are more likely developing symptoms, but aren’t at a critical state where they would be put in an ICU. According to DeSantis, data from clinical trials found a 70% reduction in hospitalized patients who used the treatment. He said another company, Regeneron, is also is working on developing a similar treatment. “We surveyed all hospitals in Florida to determine demand. We sent that information to the federal government and the Health and Human Services department used that information and have now sent over 3,000 doses of the treatment directly to hospitals,” DeSantis said. The treatments have gotten to the hospitals “within the past few days.” DeSantis said Health and Human Services will send approximately the same amount of the treatment every week for the foreseeable future. “We are going to continue to work with hospitals and other providers to ensure that qualifying individuals have access to this treatment,” he said. A Lee Health representative also said its hospitals have received a monoclonal antibody called Bamlanivmab, which isn’t considered a “cocktail” because it only contains one antibody type. Lee County COVID-19 vaccine site moving to North Fort Myers this month June 13, 2021 AdvertisementTags: covid-19 vaccineGovernor Ron DeSantis DOH-Collier bringing COVID-19 vaccines to homebound residents June 17, 2021 Advertisement“We have purchased 5 million syringes, 5 million needles and 5 million alcohol swabs,” DeSantis said in his announcement. Pfizer’s vaccine, which currently has a 95% effectiveness rate, needs to be stored in negative 70-degree temperatures, according to the Governor. “The state of Florida has identified 5 different hospital systems who have the ability to store the vaccine at those temperatures and administer that to the qualifying individuals,” he said. center_img Advertisement Mobile pediatric clinic provides COVID vaccines for children 12+ June 15, 2021 AdvertisementRecommended ArticlesBrie Larson Reportedly Replacing Robert Downey Jr. As The Face Of The MCURead more81 commentsGal Gadot Reportedly Being Recast As Wonder Woman For The FlashRead more29 comments Advertisement AdvertisementDC Young Fly knocks out heckler (video) – Rolling OutRead more6 comments’Mortal Kombat’ Exceeded Expectations Says WarnerMedia ExecutiveRead more2 commentsDo You Remember Bob’s Big Boy?Read more1 commentsKISS Front Man Paul Stanley Reveals This Is The End Of KISS As A Touring Band, For RealRead more1 comments DeSantis said the state of Florida has been working on preparing for vaccine distribution since July. This includes buying necessary supplies. last_img read more

48,000 businesses already registered to offer workplace testing

first_img48,000 businesses already registered to offer workplace testing Regular, rapid testing will be a crucial tool to prevent outbreaks in the workplace as we cautiously ease restrictions, keeping employees safe and businesses openA major expansion of the free programme now means all businesses can access workplace testing, and are encouraged to register their interest by 31 MarchOver 48,000 businesses have registered their interest in the government’s free workplace testing programme, using rapid lateral flow tests that can give a result in 30 minutes.Over 9,000 businesses have already completed the sign-up process, and all other businesses are encouraged to register by 31 March to help keep their employees safe, prevent outbreaks and suppress the spread of the virus. Businesses are encouraged to register before 31 March, even if they’re not yet open or are not able to start using the tests straight away.Around 1 in 3 people with coronavirus do not have symptoms, which means they could be spreading the virus in workplaces without knowing. Rapid testing for people without symptoms detects cases quickly, meaning positive cases can isolate immediately, breaking chains of transmission.Testing will form a crucial part of everyday life as parts of society reopen. Regular testing could be the difference between a workplace being able to stay open and operational, or needing to close due to a COVID-19 outbreak.New analysis by NHS Test and Trace shows lateral flow (LFD) tests to have a specificity of at least 99.9%. This means that for every 1,000 lateral flow tests carried out, there is less than one false positive result.Secretary of State for Health and Social Care Matt Hancock said:We have built a huge asymptomatic testing system from scratch, which is an essential part of our plan to reopen cautiously.Rapid testing has been rolled out at a vast scale across a range of sectors, and it is fantastic that now over 48,000 businesses have signed up to offer rapid testing to employees. This is a huge step forward in getting businesses back on their feet and helping to keep people safe.With around 1 in 3 people with the virus not having symptoms, regular testing is essential to bearing down on the virus and identify new variants of concern as we work towards restoring normal life. I strongly encourage all businesses to register their interest before the 31 March deadline.Businesses have until 31 March to register for the government’s workplace testing scheme, which will remain free until the end of June. Businesses of any size, including those with fewer than 50 employees, can sign up to offer workplace testing. Those who need to leave home for work can also access regular testing through community testing, which is now offered by all local authorities in England.Regular, rapid testing is already in place for millions of people across the NHS, care homes and schools. The government has also confirmed twice-weekly testing using LFDs for free to all adults in households with nursery, primary, secondary school and college-aged children and young people, including childcare and support bubbles.This is in addition to the 2 tests for all secondary and college students and staff per week. Staff at private, voluntary and independent nurseries also have access to rapid testing through their workplace.Case studiesPhillips 66 Humber RefineryPhillips 66 Humber Refinery produces up to 14 million litres, with around 20% of all UK petroleum products coming from the Humber Refinery. They are testing over 1,000 staff a week and have almost completed 10,000 tests in total.Darren Cunningham, Lead Executive UK and General Manager at Humber Refinery, said:When offered the opportunity to take part in lateral flow testing, we jumped at the opportunity. Why wouldn’t we? It is another layer of protection to keep our staff, their families and our communities safer. The operation to set up large-scale testing for 1,000 staff weekly – and it did pose some challenges – we are now running smoothly, and happily sharing what we did to help other key industries set up their own LFT facility.Siemens MobilitySiemens Mobility has been a leader in transport solutions for more than 160 years and now employs 36,800 people worldwide, with 4,500 of those in the UK. The organisation’s core areas are rolling stock, rail automation and electrification, turnkey systems and intelligent traffic systems. In total, Siemens Mobility operates from around 70 UK locations.William Wilson, CEO of Siemens Mobility Limited, said:Our people have played vital roles throughout the pandemic maintaining critical national infrastructure and helping essential services to operate safely and efficiently. As we move towards the relaxation of lockdown rules, introducing regular COVID-19 testing, with almost instant results, plays a vital role in helping to track and contain virus spread, as well as provide our employees with peace of mind.Unipart GroupUnipart Group is a leading UK manufacturer, full-service logistics provider and consultant headquartered in Oxford. Unipart operates across a range of market sectors, including automotive, healthcare and the NHS, manufacturing, mobile telecoms, rail, retail and technology. Around 130 workers are tested every week – 90% of the workforce working from this site.Debs Astles, Unipart Group HR Director – Corporate Responsibility and Policy, said:Encouraging our people to get regular tests is an important part of our COVID-safe commitment across our sites, and helps us support our colleagues’ safety and wellbeing. This ensures we can continue to provide essential services to customers across key sectors such as healthcare and the NHS, automotive, essential retail and the construction industry.Birchall FoodserviceBirchall Foodservice is an independent, family-owned business with depots in Burnley, Durham, Sheffield and Stoke-on-Trent. The company employs 150 people. Birchall Foodservice delivers a ‘one-stop shop’ range of foods, drinks, non-foods and equipment to caterers working in the care, education and hospitality sectors.Louise Birchall, sales director at Birchall Foodservice, said:The introduction of rapid testing allows us to quickly identify asymptomatic cases of coronavirus within the business. By isolating these cases, we can stop any potential spread of COVID-19 and help protect our employees, their families and our customers. We are encouraging all local businesses, no matter the size, to introduce frequent, rapid testing amongst their workforce.The Glasdon GroupThe Glasdon Group is a design and manufacture company specialising in litter and recycling bins, road safety products, a diverse range of building systems, shelters, seating products, water safety products and snow-clearing equipment. The company employs over 250 employees and is based in Blackpool, Lancashire. They have been carrying out testing via their local authority, Blackpool Council, since December 2020, and they now have 5 testing stations where they can process up to 60 tests per hour. The company carries out approximately 400 tests per week.Gary Butler, Health and Safety Manager at the Glasdon Group, said:Testing all of our staff and any visiting contractors twice per week is providing us with the confidence that our own control measures are having the desired result of protecting our employees during the pandemic. The rapid test results enable us to isolate any affected staff as quickly as possible, thus reducing the chance of an outbreak on the premises.The response of the Glasdon employees to the testing programme has been positive and is going a long way to making them feel safe in their place of work during these difficult times. Testing twice per week is also providing a level of assurance to the employees’ families that they are not putting their own households at extra risk by coming to work.Background informationBusinesses have until 31 March to register for the government’s workplace testing scheme, which will remain free until the end of June. /Public Release. This material comes from the originating organization and may be of a point-in-time nature, edited for clarity, style and length. View in full here. Why?Well, unlike many news organisations, we have no sponsors, no corporate or ideological interests. We don’t put up a paywall – we believe in free access to information of public interest. Media ownership in Australia is one of the most concentrated in the world (Learn more). Since the trend of consolidation is and has historically been upward, fewer and fewer individuals or organizations control increasing shares of the mass media in our country. According to independent assessment, about 98% of the media sector is held by three conglomerates. This tendency is not only totally unacceptable, but also to a degree frightening). Learn more hereWe endeavour to provide the community with real-time access to true unfiltered news firsthand from primary sources. It is a bumpy road with all sorties of difficulties. We can only achieve this goal together. Our website is open to any citizen journalists and organizations who want to contribute, publish high-quality insights or send media releases to improve public access to impartial information. You and we have the right to know, learn, read, hear what and how we deem appropriate.Your support is greatly appreciated. All donations are kept completely private and confidential.Thank you in advance!Tags:Butler, construction industry, coronavirus, Government, health, health and safety, infrastructure, Oxford, road safety, secondary school, secretary of state, Sheffield, Siemens, technology, UK, UK Government, water safetylast_img read more

National Academy of Sciences inducts 2 CU Boulder professors

first_img Published: May 7, 2018 • By Colorado Arts and Sciences Magazine Professor Natalie Ahn (left) and Professor Karolin Luger.Pioneering biochemists Natalie Ahn and Karolin Luger have been inducted into the National Academy of Sciences, an honor that recognizes “distinguished and continuing achievements in original research.” Membership in the prestigious organization is widely considered to be one of the highest honors that a scientist can receive.”It’s really a wonderful recognition of our work and a great honor that I share with all of my coworkers, past and present,” said Luger, a professor in the Department of Chemistry and Biochemistry and the Jennie Smoly Caruthers Endowed Chair of Biochemistry.Luger and her colleagues study how genetic material is stored in human cells and how these organizational principles critically affect every aspect of cell life in health and disease. Understanding and visualizing protein-DNA assemblies at atomic resolution will allow researchers to better understand how the genome is decoded by the cell’s machinery.In 2017, Luger—who is also a Howard Hughes Medical Institute (HHMI) Investigator—published research on the genomic structure of microbes called Archaea, findings that hinted at the evolutionary origins of DNA folding that all multicellular organisms use. The research built on Luger’s cornerstone scientific achievement, which outlined the three-dimensional structure of the nucleosome. That finding, now widely cited in textbooks, was named the “breakthrough of the year” in 1997 by the journal Science.Ahn joined the CU Boulder faculty in 1992 and served as an HHMI Investigator from 1994–2014. She serves as President of the American Society of Biochemistry and Molecular Biology. “This is such a great honor,” said Ahn, a Professor of Distinction in Chemistry and Biochemistry and Associate Director of the BioFrontiers Institute. “I owe many thanks to my past mentors, and to my wonderful colleagues, students and friends in our amazing CU Boulder community.”Ahn’s research focuses on enzymatic and cellular mechanisms underlying cell signal transduction. She conducted pioneering work in the discovery of the mitogen-activated protein (MAP) kinase cascade, including the identification of MAP kinase kinases which are important targets for anti-cancer therapies. She was also a pioneer in the use of functional proteomics and mass spectrometry for signal transduction research.The 2018 class of National Academy of Sciences inductees includes 84 researchers from across the country as well as 21 foreign associates. The new inductees bring the total number of active members to 2,382 and the total number of foreign associates to 484.Categories:Deadlines & AnnouncementsCelebrateCampus Community Share Share via TwitterShare via FacebookShare via LinkedInShare via E-maillast_img read more

CCCD Expands Programme for Deaf Children

first_imgRelatedCCCD Expands Programme for Deaf Children RelatedCCCD Expands Programme for Deaf Children CCCD Expands Programme for Deaf Children CultureMarch 5, 2010 Advertisementscenter_img FacebookTwitterWhatsAppEmail It is said that “a good education is the key to success” and, as such most, if not all able bodied persons always strive for the best in educational opportunities for themselves and their children, with a view to realizing social, economic and other improvements in their lives.Whereas for persons with all their physical faculties intact, achieving a good educational training can be easy for some, and not so easy for others based on their learning abilities, one can imagine the degree of difficulty there is for persons not so fortunate to have all their physical faculties intact, to achieve a good educational start in life.In such cases special attention, care and tutoring, which calls for great patience, skill and professionalism, are necessary to assist those unfortunate ones with their disabilities.This is where the work of the Caribbean Christian Centre for the Deaf, located in the tough inner-city community of Granville, St. James, becomes important, as it caters only to youngsters with hearing disabilities, trying to prepare them for life in general, and how to become independent, productive individuals.With approximately 164 public educational institutions in the Ministry of Education’s (MOE) region 1V, which takes in the parishes of St. James, Hanover and Westmoreland, the Caribbean Christian Centre for the Deaf (CCCD) holds the distinction of being the only MOE recognized institution of its kind in the parish of St. James.It started operating in 1990, receiving its first student in 1994 and, based on its recognized independent school status by the MOE, it receives a stipend from that ministry as a form of financial support and constant monitoring and supervision from an assigned Education Officer.The Granville institution is one of three such institutions catering solely to deaf persons, being operated by the Caribbean Christian Centre, a non-government organization. The others are in Kingston and Knockpatrick, Manchester.Students of the Caribbean Christian Centre for the Deaf, in Granville, St. James, communicating with each other through sign language, on the compound of their institution. The institution has been tutoring children with hearing disability since 1994.The Granville school has 54 students on roll, ranging in age from 5 to 20 years, who are taught subjects like in any regular educational institution, but with a difference where all tutoring and instructions are given through sign language.“They learn the normal subjects like in any normal school, but these we have to modify in order to teach them. We have subjects like Math, English, Language Arts, the sciences, etcetera, and then we have vocation areas,” Principal of the institution, Dorreth Russell, told JIS News.“We have linked up with HEART Trust/NTA, and the subjects that we do are Food Preparation, Information Technology, Cosmetology and Sewing and next term we will be introducing Woodwork,” she continued.She explained that the school receives its students mainly through referrals, word of mouth, some from the St. Christopher School for the Deaf, and also through its own outreach programmes, where it checks in homes and schools for students who are not performing, in a lot of instances, because they are deaf.She went on to mention the latest in the educational achievements of students of the institution, which includes six of her students attending the University of The West Indies’ (UWI) Western Campus in Montego Bay.“Right now we have some students who are doing a university project with the UWI. They are doing Early Childhood Education, six of them we have in the class right now. We do that with interpreters, and they are doing extremely well”, she boasted.Students of the Caribbean Christian Centre for the Deaf, in Granville, St. James, communicating with each other through sign language, on the compound of their institution. The institution has been tutoring children with hearing disability since 1994.She explained that the prgramme of study is a one-year certificate programme, adding that the six students are the first deaf students to attend the UWI’s Montego Bay campus.She informed that the whole idea of the deaf students attending the UWI Western Campus in Montego Bay is creating so much attention, to the extent that discussions are now taking place between the CCCD Granville Campus and the UWI with a view to having the implementation of a sign language programme on the university campus.But with the CCCD Granville being a residential learning institution, the question was asked of The Principal, Mrs. Russell, as to “how costly is it to the parents of the students”?She explained that it is quite minimal as the Caribbean Christian Centre seeks sponsorship for the students, both locally and overseas, and the Granville institution tries various fundraising efforts to help in underwriting some of its expenses.She also pointed out that the current economic crisis is having an effect as, even with the minimal $12,000 per term asked per student, some parents cannot afford it. On top of that, the level of overseas sponsorship has fallen dramatically, as a number of original contributors to the cause are having their personal economic problems at this time.She gave a commitment that the administrators of the schools will continue to do everything possible to keep the institution open and the students in school, but issued an appeal for the Jamaican community to play its part in assisting the institution and the students.“The children in fact are our children, and we need to care for them”, she stated.She explained that persons wishing to contribute to the cause can contact the Caribbean Christian Centre in Knockpatrick, Manchester, or Granville, St. James.To compliment the academic achievements of the students of the CCCD, Mrs. Russell also proudly pointed to the school’s shelves full of trophies won in the Jamaica Cultural Development Commission’s (JCDC) Arts competitions.The school has won trophies in dancing, both nationally and locally; for Best School; best dancers; best choreographed; and top dance teacher, among others.Sign language classes are taught at the CCCD Granville campus twice per week. RelatedCCCD Expands Programme for Deaf Childrenlast_img read more

JCDC Ready for Festival Activities

first_imgFacebookTwitterWhatsAppEmail KINGSTON — Preparations are in high gear for the Jamaica Cultural Development Commission’s (JCDC)-organised Independence festival activities, which kick off on Friday night (July 29) with the Festival Song finals at the National Arena in Kingston. The show, which gets underway at 8:00 p.m., will see the 10 finalists competing for the top prize of one million dollars courtesy of CLARO and a brand new Nissan Tida from Fidelity Motors, plus other prizes. Speaking at the JIS Think Tank on Wednesday, July 27, at the agency’s head office in Kingston, Acting Executive Director of the JCDC, Delroy Gordon, said preparations are well advanced for this event and others. “We are prepared as we need to be today for the first event. Quite a number of activities are going on in various communities, particularly in the inner-city where persons are now involved in creating various costumes for the Grand Gala,” he said. Mr. Gordon said that plans for the coronation of the Miss Jamaica Festival Queen are progressing smoothly. The show will take place on Saturday, July 30 at the National Arena starting at 8:00 p.m. under the theme: ‘Jamaican Women Shaping Our Culture.’ He informed that the 13 contestants are now in Kingston and have been attending various events, including courtesy calls on the Governor-General, the Prime Minister, the Leader of the Opposition and the Mayor. On Sunday, July 31, the Jamaica Gospel Song competition will be held at the National Arena starting at 7:00 p.m. Top prize is $500,000 courtesy of Grace Tropical Rhythms. Meanwhile, participants in the World Reggae Dance Championship have been rehearsing at the Ranny Williams Entertainment Centre in preparation for the show on Monday, August 1 at the National Arena commencing at 8:00 p.m. “This event is one of the fastest growing events of the JCDC in terms of popularity. Last year and the year before, we had competitors coming from as far as Japan and this year promises to be just as exciting,” Mr. Gordon said. The popular Mello Go Roun’ featuring the best in the festival of the performing arts, will take place on Thursday, August 4 at the National Arena beginning at 8:00 p.m. Activities culminate on Saturday, August 6 with the colour and spectacle of the Independence Grand Gala at the National Arena, starting at 5:00 p.m. In addition to the major events being organised by the JCDC, Mr. Gordon said that the Commission will be collaborating with a number of organisations and independent promoters in the staging of other activities. Among these are the Ocho Rios Seafood Festival, Turtle River, St. Ann and the Camfest (Cambridge Festival) in Cambridge, St. James on Independence Day, August 6; and the Independence Fair and Stage Show at the Aqueduct in Rose Hall, St. James on Monday, August 7. The Acting Executive Director thanked the many sponsors as well as volunteers for their support. “We are fully aware that in spite of our collective efforts, our accomplishments would not have been realised without the generous contributions of our faithful and dedicated sponsors, volunteers, participants and other friends of the cultural movement, to whom we owe a debt of gratitude,” Mr. Gordon added. Major sponsors are CLARO, CHASE Fund, the Tourism Enhancement Fund (TEF), GraceKennedy, Fidelity Motors, Christar Villas Hotel, Excelsior, Jamaica Cooperative Credit Union League, Kingston and St. Andrew Corporation (KSAC), Independence Park Limited, TVJ, CVM, JIS, Public Broadcasting Corporation of Jamaica (PBCJ) and Creative Production and Training Centre (CPTC). By E. Hartman Reckord, JIS PRO RelatedJCDC Ready for Festival Activities RelatedJCDC Ready for Festival Activities RelatedJCDC Ready for Festival Activitiescenter_img Advertisements JCDC Ready for Festival Activities CultureJuly 28, 2011last_img read more